Metraipolis › archive › dc_1fcf03bbc741

Targeted therapies and resistance mechanisms in lymphoma: Current landscape and emerging solutions — Europe PMC PMID:41090103

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41090103
DOI
10.18632/oncoscience.633
License (as archived)
solo-consultazione
Archived
2026-11-09T09:21:46.883Z
SHA-256 of the archived text
57f6a764aaee2e75495d29c558f1967c2c74e555431198bab139b0ff87d021be
Stable URL of this page
https://metraipolis.com/documento/dc_1fcf03bbc741

How to cite

Targeted therapies and resistance mechanisms in lymphoma: Current landscape and emerging solutions — Europe PMC PMID:41090103 — Europe PMC (en), https://europepmc.org/article/MED/41090103 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1fcf03bbc741 (Metraipolis archive dc_1fcf03bbc741, sha256 57f6a764aaee2e75495d29c558f1967c2c74e555431198bab139b0ff87d021be)
BibTeX
@misc{dc1fcf03bbc741,
  title = {Targeted therapies and resistance mechanisms in lymphoma: Current landscape and emerging solutions — Europe PMC PMID:41090103},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41090103},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1fcf03bbc741; sha256 57f6a764aaee2e75495d29c558f1967c2c74e555431198bab139b0ff87d021be},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41090103. Agents can read the archived copy with the MCP tool read_document.